LeucodermL81.5

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 06.07.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Circumscribed, temporary, post-inflammatory depigmentation due to different mechanisms, which occurs during or in the wake of skin diseases or their treatment (intra- and/or perilesional), e.g. in pityriasis versicolor, atopic eczema, psoriasis vulgaris in syphilistic exanthema (syphilitic leukoderm) The size of the depigmentations is defined by the preceding lesions.

EtiopathogenesisThis section has been translated automatically.

Chemical inhibition of melanogenesis, disturbance in the transport mechanism of melanosomes, UV absorption in scale deposits.

The so-called pseudoleukoderm does not involve disorders of melanocyte function but simple contrast phenomena which occur as in Psseudoleucoderma psoriaticum due to dithranol staining of the surrounding healthy skin.

Clinical featuresThis section has been translated automatically.

Diseases that can trigger or are associated with leukoderms:

TherapyThis section has been translated automatically.

Therapy is not necessary. Cover with camouflage e.g. Covermark, Dermacolor. If necessary, treatment of the underlying disease.

Authors

Last updated on: 06.07.2021